Intravascular hemolysis following low dose daily rifampin

    loading  Checking for direct PDF access through Ovid

Abstract

We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses. Pediatr Blood Cancer 2008;51:821–823. © 2008 Wiley-Liss, Inc.

Related Topics

    loading  Loading Related Articles